Prudential Financial
STLN

Prudential Financial’s Starling Oncology STLN Stock Holding History

Prudential Financial’s Portfolio STLN Stock Details STLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$146K Buy
26,825
+300
+1% +$1.26K ﹤0.01% 2284
2026
Q1 		$81.4K Buy
26,525
+11,760
+80% +$36.1K ﹤0.01% 2256
2025
Q4 		$52.6K Sell
14,765
-2,970
-17% -$11K ﹤0.01% 2145
2025
Q3 		$61.9K Buy
+17,735
New +$60.8K ﹤0.01% 2319
2024
Q2 		– Sell
-23,800
Closed -$37.6K – 2789
2024
Q1 		$37.6K Hold
23,800
– – ﹤0.01% 2616
2023
Q4 		$48.6K Buy
23,800
+10,800
+83% +$18.7K ﹤0.01% 2555
2023
Q3 		$18.2K Buy
+13,000
New +$13.5K ﹤0.01% 2574

Other funds holding STLN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JAIC
Josh Arnold Investment Consultant Edina, Minnesota $159M AUM 142.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Prudential Financial's STLN Position: Q2 2026 in Review

Prudential Financial increased its Starling Oncology (STLN) stake by 1.1% in Q2 2026, buying an estimated $1.26K and bringing the position to 26,825 shares worth $146K. The position accounts for ﹤0.01% of the portfolio, ranked #2284.

Prudential Financial first reported a position in STLN in Q3 2023 and has held it in 7 quarters since. 119 funds tracked by Wall St. Rank hold STLN as of Q2 2026.

  • Prudential Financial held 26,825 shares of Starling Oncology worth $146K as of Q2 2026.
  • Prudential Financial bought 300 Starling Oncology shares in Q2 2026, an estimated $1.26K.
  • Starling Oncology made up ﹤0.01% of Prudential Financial's portfolio in Q2 2026, its #2284 holding.
  • Prudential Financial first reported a position in Starling Oncology in Q3 2023 and has held it in 7 quarters since.
  • 119 funds tracked by Wall St. Rank held Starling Oncology as of Q2 2026.

Based on Prudential Financial's 13F filing for Q2 2026, filed 12 Aug 2026.